Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000899243-21-004384

Options or other derivatives

  • Chief Medical Officer acquired 400,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Sachs Jessica Chief Medical Officer 2021-02-01 Grant or award · Stock Option (Right to Buy) +400,000 400,000 D
Loading xslF345X03/doc4.xml…